Latest Alterra Capital Holdings Ltd (ALTE) Headlines CSG

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Alterra Capital Holdings Ltd (ALTE) Headlines

CSG Partners Named Boutique Investment Banking Firm of the Year by the M&A Advisor
PR Newswire - Fri Dec 20, 5:30AM CST
CSG Partners, LLC was named the "Boutique Investment Banking Firm of the Year" by the M&A Advisor on December 17th 2013, at the 12th Annual M&A Advisor Awards. The awards are an annual tribute to the outstanding achievements of leading dealmakers, firms and transactions.

Bryan Sanders to Succeed John Latham as President of Markel Wholesale
PR Newswire - Thu Oct 10, 12:00PM CDT
F. Michael Crowley, President and Co-Chief Operating Officer of Markel Corporation (NYSE: MKL), has announced that John Latham is stepping down as President of Markel Wholesale effective December 31, 2013 and will be succeeded by Bryan Sanders. Sanders, who currently serves as Executive Vice President of Markel's Wholesale division, joined Markel with the acquisition of Alterra Capital Holdings Limited. Latham will transition to a consultative role, active with Markel, working out of Markel's Plano, TX, regional office. This transition marks the next step in a long and distinguished career in insurance. Sanders will remain based in Markel's home office in Richmond, VA, and report to Crowley.

A.M. Best Affirms Ratings of Alterra Capital Holdings Limited and Its Operating Subsidiaries
Business Wire - Fri Aug 09, 9:38AM CDT
A.M. Best Co. has affirmed the financial strength rating (FSR) of A (Excellent) and issuer credit ratings (ICR) of "a" of Alterra Bermuda Limited (Alterra Bermuda) and its affiliated operating companies.

Markel Misses Earnings, Beats Rev - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 08, 8:51AM CDT
Markel Corporation reported operating earnings of $5.13 per share

Markel Reports First Quarter 2013 Results
PR Newswire - Tue Apr 30, 3:33PM CDT
Markel Corporation (NYSE - MKL) reported diluted net income per share of $9.50 for the quarter ended March 31, 2013 compared to $5.92 for the first quarter of 2012. The results for the first quarter of 2013 reflect more favorable underwriting results compared to the same period of 2012. The combined ratio for the first quarter of 2013 was 91% compared to 100% for the first quarter of 2012. The combined ratio for the first quarter of 2012 included $20 million, or four points, of underwriting, acquisition and insurance expenses related to the Company's prospective adoption of Financial Accounting Standards Board Accounting Standard Update No. 2010-26, Accounting for Costs Associated with Acquiring or Renewing Insurance Contracts. Book value per common share outstanding increased 7% to $431.10 at March 31, 2013 from $403.85 at December 31, 2012.

KBW and its subsidiary declare changes to KBW Property & Casualty Index
M2 - Mon Apr 29, 9:04AM CDT
A wholly owned subsidiary of Stifel Financial Corp (NYSE:SF), a full-service, boutique investment bank and broker-dealer that specialises in the financial services sector Keefe, Bruyette & Woods Inc disclosed on Friday that before business opens on 1 May, certain changes will occur to KBW Property & Casualty Insurance Index (Index Ticker:KPXSM) (ETF Ticker:KBWPSM).

Zacks Bull and Bear of the Day Highlights: Tower International, UTi Worldwide, Markel, Alterra Capital Holdings and Everest Re
PR Newswire - Thu Apr 18, 8:30AM CDT
Zacks Equity Research highlights Tower International, Inc. (NYSE:TOWR) as the Bull of the Day and UTi Worldwide Inc. (Nasdaq:UTIW) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Markel Corp. (NYSE:MKL), Alterra Capital Holdings Ltd. (Nasdaq:ALTE) and Everest Re Ltd. (NYSE:RE).

Markel Corp.: A Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 17, 12:50PM CDT
On Apr 16, 2013, Zacks Investment Research upgraded Markel Corp. (MKL) to a Zacks Rank #1 (Strong Buy).

WEALTHMAKERS.COM Issues Bearish Research Reports on AJG, ALTE, ARCC, CGNX, CRVL, ECT
M2 - Wed Apr 17, 10:48AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Arthur J. Gallagher & Co (NYSE:AJG), Alterra Capital Holdings Ltd (NASDAQ:ALTE), Ares Capital Corp (NASDAQ:ARCC), Cognex Corp (NASDAQ:CGNX), CorVel Corp (NASDAQ:CRVL), ECA MARCELLUS TRUST I (NYSE:ECT)

3 Reasons Buffett Should Buy Markel
Steve Symington, The Motley Fool - Motley Fool - Tue Apr 09, 1:34PM CDT
Shortly after Berkshire Hathaway CEO Warren Buffett spent $12 billion in cash last month to acquire 50% of  H.J. Heinz  , he told the world he was ready for more . Of course, there's certainly reason to believe the man given his past...

WEALTHMAKERS.COM Issues Bearish Research Reports on ADVS, AIV, ALTE, ARB, CREE, ELP
M2 - Thu Apr 04, 12:11PM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Advent Software Inc (NASDAQ:ADVS), Apartment Investment and Management Co (NYSE:AIV), Alterra Capital Holdings Ltd (NASDAQ:ALTE), Arbitron Inc (NYSE:ARB), Cree Inc (NASDAQ:CREE), Copel Companhia Paranaense de Energia (NYSE:ELP)

A.M. Best Rates Markel Corp's Debt - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 13, 2:20PM CDT
A.M. Best Co. has allotted a debt rating of bbb+ to Markel Corporation Inc.

Alterra Shareholders Approve Markel Merger
Rich Smith, The Motley Fool - Motley Fool - Tue Feb 26, 7:23PM CST
On Tuesday, specialty insurers Markel and Alterra Capital Holdings announced that their respective shareholders have "overwhelmingly" voted to approve the merger of the two companies. Assuming regulators approve, and other usual closing...

Markel And Alterra Shareholders Overwhelmingly Approve Acquisition
PR Newswire - Tue Feb 26, 10:23AM CST
Markel Corporation (NYSE: MKL) ("Markel") and Alterra Capital Holdings Limited (NASDAQ: ALTE; BSX: ALTE.BH) ("Alterra") today announced that their respective shareholders have voted in favor of all proposals necessary for the acquisition of Alterra by Markel. Completion of the transaction remains subject to receipt of regulatory approvals and other customary closing conditions and is expected to occur in the second quarter of 2013.

The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Alterra Capital Holdings Limited in Connection With the Sale of the Company to Markel Corp. -- ALTE
GlobeNewswire - Mon Feb 11, 9:53AM CST
Levi & Korsinsky notifies investors of Alterra Capital Holdings Limited ("Alterra" or the "Company") (Nasdaq:ALTE) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to Markel Corp. ("Markel"). A complaint was filed in New York Federal court.

After a Solid 2012, What's Next for Markel?
Steve Symington, The Motley Fool - Motley Fool - Sat Feb 09, 11:30AM CST
With the release of its strong fourth-quarter earnings report Monday, specialty insurer Markel effectively capped what has arguably turned out to be its most eventful year of the past decade.   Normally that wouldn't be saying much given...

Alterra Capital declares dividend of USD0.16 per share
M2 - Wed Feb 06, 7:31AM CST
The board of directors of Alterra Capital Holdings Limited (NASDAQ:ALTE) (BSX:ALTE.BH), a provider of diversified specialty insurance and reinsurance products, has approved a dividend of USD0.16 per share, the company reported on Tuesday.

1-Minute Earnings Review: Markel
Matt Koppenheffer, The Motley Fool - Motley Fool - Tue Feb 05, 4:07PM CST
Markel , a niche insurance company that many investors view as a "Baby Berkshire Hathaway " due to its value investing style that mirrors many of Warren Buffett's decisions, has reported its quarterly earnings. In this video, Motley...

Alterra Capital Reports Fourth Quarter and Year End 2012 Results
Business Wire - Tue Feb 05, 3:05PM CST
--2012 Net Operating Income of $1.18 per Diluted Share

Alterra Capital Holdings Ltd (ALTE) Stock Research Links

ALTE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 170

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 211

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 268

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 227

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 234

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 84

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 186

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 193

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Updates for Edwards Lifesciences Corporation Investors

Updated Category News Views 157

Important Updates for Edwards Lifesciences Corporation Investors New York - Investors of Edwards Lifesciences Corporation (NYSE: EW) should remain aware of the recent developments concerning the securities class action lawsuit that affects their investments. This information is crucial for anyone who purchased securities of Edwards Lifesciences within the specified class...

Continue Reading
Investors Urged to Act: Zenas BioPharma Class Action Notice

Updated Category News Views 147

Investors Encouraged to Participate in Zenas BioPharma Class Action The Gross Law Firm has issued an important notice for shareholders of Zenas BioPharma, Inc. (NASDAQ: ZBIO), urging those who have incurred financial losses to seek options regarding a pending class action. This notice highlights the importance of taking timely steps for potential recovery. Understanding...

Continue Reading
Zinzino's Strategic Merger with It Works! Enhances Growth Potential

Updated Category News Views 1021

Zinzino and It Works! Merger: A Game-Changer in Health Sales Zinzino AB has officially announced a remarkable merger with the US-based direct sales company It Works!, a bold and strategic decision that is set to enhance the distribution capabilities of both companies across various markets. This merger, which combines unique strengths and resources, opens new avenues for...

Continue Reading
NEXE Innovations Expands Compostable Product Line in North America

Updated Category News Views 164

Exciting Developments at NEXE Innovations Based in Windsor, Ontario, NEXE Innovations Inc. is making significant strides in the compostable materials industry. Recently, the company announced a pivotal delivery of over 80,000 compostable coffee pods, available in three new product SKUs, to an esteemed office coffee services distributor in North America. Expanding Product...

Continue Reading
SubSplit Acquires Ideal Consolidated: Legacy Meets Future

Updated Category News Views 236

Market moves may come and go, but the real power play is knowing when a strategic acquisition is worth its weight in gold. SubSplit Services Group just pulled off one such move by nabbing Ideal Consolidated, Inc., a company that's been a fixture in South Bend, Indiana, since 1956. Yeah, that's a lot of history, folks, and SubSplit's decision to add that to their portfolio...

Continue Reading